Abstract:Protein nanoparticles (NPs), biocompatible and biodegradable, can be easily surface modified. In particular, amphiphilic proteins act as "surfactants" that help form microparticles while undergoing molecular chain rearrangement. These NPs have been successfully used as drug delivery systems, improving bioavailability and reducing the toxic effects of drug molecules. The use of regenerated silk protein (RSF) with m-acrylamidophenylboronic acid (APBA) composites as drug carriers for loading anti-inflammatory herbal extracts was reported. Firstly, a simple and rapid method was used to prepare silk protein/polyphenylboronic acid nanospheres, in brief, RSF solution and a certain amount of initiator were added to APBA solution, and the pH was adjusted by NaOH, and the polymerization was initiated by heating at 90. under nitrogen protection with stirring at 500 r/min. After 2 h of reaction, a milky solution was obtained, which formed silk protein/benzeneboronic acid nanospheres with hydrophobic interior and hydrophilic surface. The drug-loaded silk protein/polyphenylboronic acid nanospheres with an average size of 550 to 600 nm were prepared by mixing with the drug solution after dialysis and stirring at room temperature for 12 h to load the drug by adsorption. By the same method, drug-loaded albumin/polyphenylboronic acid microspheres and collagen/polyphenylboronic acid microspheres with sizes around 260 nm and 100 nm, respectively, could be prepared. The results observed by scanning and projection electron microscopy and dynamic light scattering showed that the drug-loaded silk protein/polyphenylboronic acid nanomicrospheres displayed regular spherical shape indicating smoothness and good dispersion with no obvious aggregation. The highest drug loading rate was about 13.4%, and the encapsulation rate was over 90%. Also, such drug-loaded nanospheres could achieve controlled release for about seven days and their slow release behavior was pH-responsive, with faster drug release in buffer solution at pH=5.5 than in buffer solution at pH=7.4. In addition, the synergistic interaction of the silk protein/polyphenylboronic acid nanomicrospheres with the subject drug improved its free radical scavenging rate and scavenging efficiency, which was superior to that of the direct drug delivery group. Thus, three protein/polyphenylboronic acid nanomicrospheres with different sizes, electrical properties and drug release rates may be adaptable to a wide range of intravenous and subcutaneous or intraperitoneal drug delivery needs and have great potential for clinical applications.

Phenylboronic Acid-Containing Block Copolymers: Synthesis, Self-Assembly, and Application for Intracellular Delivery of Proteins

Galactose-based polymer-containing phenylboronic acid as carriers for insulin delivery

Development of novel self-assembled poly(3-acrylamidophenylboronic acid)/poly(2-lactobionamidoethyl methacrylate) hybrid nanoparticles for improving nasal adsorption of insulin

Phenylboronic Acid Functionalized Polymer Nanocarriers for Intracellular Delivery of Protein Drugs

Amphiphilic Glycopolymer Nanoparticles As Vehicles for Nasal Delivery of Peptides and Proteins

Ph- And Glucose-Sensitive Glycopolymer Nanoparticles Based On Phenylboronic Acid For Triggered Release Of Insulin

A Poly(l-Lysine)-based Hydrophilic Star Block Co-Polymer As a Protein Nanocarrier with Facile Encapsulation and Ph-Responsive Release

A non-spherical nanoparticles system for the delivery of peptides using polymer grafted nanocellulose

Phenylboronate-diol Crosslinked Glycopolymeric Nanocarriers for Insulin Delivery at Physiological Ph.

A Glucose-Sensitive Block Glycopolymer Hydrogel Based on Dynamic Boronic Ester Bonds for Insulin Delivery.

Glucose-responsive vehicles containing phenylborate ester for controlled insulin release at neutral pH.

A hyperbranched amphiphilic acetal polymer for pH-sensitive drug delivery

Amphiphilic Random Glycopolymer Based on Phenylboronic Acid: Synthesis, Characterization, and Potential As Glucose-Sensitive Matrix

Amphiphilic QP(DMAEMA-co-LMA)-b-POEGMA Random-Block Terpolymers As Nanocarriers for Insulin

Improvement of protein loading and modulation of protein release from poly(lactide-co-glycolide) microspheres by complexation of proteins with polyanions.

Conjugates of poly(dl-lactic acid) with ethylenediamino or diethylenetriamino bridged bis(β-cyclodextrin)s and their nanoparticles as protein delivery systems

Synthesis and characterization of phenylboronic acid-containing polymer for glucose-triggered drug delivery.

Glucose-Sensitive Polyphosphoester Diblock Copolymer for an Insulin Delivery System

Synthesis and physicochemical characterization of a novel amphiphilic polylactic acid-hyperbranched polyglycerol conjugate for protein delivery

POLY(D, L- LACTIDE) NANOPARTICLES CONTAINING PROTEIN I. PREPARATION AND CHARACTERIZATION

Preparation of the Protein/Polyphenylboronic Acid Nanospheres for Drug Loading and Unloading